Liver Injury and Changes in Hepatitis C Virus (HCV) RNA Load Associated with Protease Inhibitor-Based Antiretroviral Therapy for Treatment-Naive HCV-HIV-Coinfected Patients: Lopinavir-Ritonavir versus Nelfinavir-Reference-Cited by-同舟云学术

Liver Injury and Changes in Hepatitis C Virus (HCV) RNA Load Associated with Protease Inhibitor-Based Antiretroviral Therapy for Treatment-Naive HCV-HIV-Coinfected Patients: Lopinavir-Ritonavir versus Nelfinavir

Published:2005-10-15 Issue:8 Volume:41 Page:1186-1195
ISSN:1058-4838
Container-title:Clinical Infectious Diseases
language:en
Short-container-title:Clinical Infectious Diseases

Author:

Sherman K. E.,Shire N. J.,Cernohous P.,Rouster S. D.,Omachi J. H.,Brun S.,Silva B. D.

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Link

http://academic.oup.com/cid/article-pdf/41/8/1186/1080111/41-8-1186.pdf

Reference19 articles.

1. Hepatitis C Virus Prevalence among Patients Infected with Human Immunodeficiency Virus: A Cross-Sectional Analysis of the US Adult AIDS Clinical Trials Group

2. Increasing Mortality Due to End-Stage Liver Disease in Patients with Human Immunodeficiency Virus Infection

3. Hepatitis C virus infection in HIV-infected patients

4. Immune recovery is associated with persistent rise in hepatitis C virus RNA, infrequent liver test flares, and is not impaired by hepatitis C virus in co-infected subjects

5. Increase in Hepatitis C Virus Load in Hemophiliacs during Treatment with Highly Active Antiretroviral Therapy

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety considerations in the management of hepatitis C and HIV co-infection;Expert Opinion on Drug Safety;2023-04-27

2. Drug-induced liver injury associated with lopinavir-ritonavir in patients with COVID-19: a disproportionality analysis of U.S. food and drug administration adverse event reporting system (FAERS) data;International Journal of Clinical Pharmacy;2021-07-30

3. Drug‐induced organ injury in coronavirus disease 2019 pharmacotherapy: Mechanisms and challenges in differential diagnosis and potential protective strategies;Journal of Biochemical and Molecular Toxicology;2021-05-11

4. Risk factors for COVID-19-related liver injury;World Chinese Journal of Digestology;2020-08-08

5. Clinical Features of COVID-19-Related Liver Functional Abnormality;Clinical Gastroenterology and Hepatology;2020-06